40 results
424B5
ASLN
ASLAN Pharmaceuticals Ltd
12 Apr 24
Prospectus supplement for primary offering
8:15am
as our agents will not have any responsibility in respect of the validity or performance of delayed delivery contracts.
One or more firms, referred
424B5
ASLN
ASLAN Pharmaceuticals Ltd
14 Mar 24
Prospectus supplement for primary offering
6:24am
, you should not rely on it. We and the placement agent take no responsibility for, and can provide no assurance as to the reliability of, any other … such securities not sold for delayed delivery. The underwriters and other persons acting as our agents will not have any responsibility in respect
6-K
EX-10.1
smn yzrz7icfjj31q2
13 Mar 24
Aslan Pharmaceuticals Announces $5 Million Registered Direct Offering
7:27am
F-6EF
EX-99
8tq137
26 Apr 23
Automatic registration for ADRs (foreign)
5:26pm
424B5
q9fupxn27 0vfbbye
13 Sep 22
Prospectus supplement for primary offering
4:05pm
6-K
EX-10.1
j0rt8 2uhngdz
14 Jul 21
Current report (foreign)
6:04am
6-K
EX-1.1
jamrjvm0fo3i beumm
4 Mar 21
Aslan Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares
6:07am
424B5
r28yzz6582kud8eq
4 Mar 21
Prospectus supplement for primary offering
6:06am
424B5
zsb6nvi2 rly8w5261
1 Mar 21
Prospectus supplement for primary offering
5:08pm
6-K
EX-99.2
dq2bfw3yizat9vi8k1
1 Mar 21
Current report (foreign)
4:02pm
F-3/A
u9qvu
9 Feb 21
Shelf registration (foreign) (amended)
6:09am
F-3
d5ilzpa41xl
29 Jan 21
Shelf registration (foreign)
4:51pm
424B5
8h70b5n vtjueg2
9 Oct 20
Prospectus supplement for primary offering
5:03pm
6-K
EX-99.1
tbgjfaqv5pt
9 Oct 20
Current report (foreign)
4:03pm
6-K
EX-99.5
r8lk1hj05af8xqaas
9 Oct 20
Current report (foreign)
4:03pm